# Advent Life Sciences

Source: https://capitalatlas.ai/funds/advent-life-sciences

> Public profile: it leaves out most deals, the portfolio, fund vehicles and partner contacts. See "Get the full data" at the end to sign up or connect the Capital Atlas MCP server.

Advent Life Sciences is a United Kingdom-based venture capital firm focused on providing equity capital and active support to life sciences companies. The firm invests in early- and mid-stage businesses engaged in drug discovery, medical technology, enabling technologies, and vaccines, and works closely with management teams through development and clinical progress. Advent Life Sciences focuses on opportunities across the United Kingdom, Europe, and the United States.

## Facts

- Type: Venture Capital Firm
- Headquarters: London, UK
- Founded: 2006
- Website: http://www.adventls.com/
- Estimated dry powder: $7.1M
- Latest fund: BioMotiv, $145.7M
- Estimated cheque size: $1.8M–$10.8M
- Stages: Seed, Series A, Series B, Series C, Series D, Series E, Series H, Venture Debt, Early Stage
- Sectors: Healthcare, Industrials
- Regions: Europe
- Last seen investing: Dec 2025
- Investments in the last 12 months: 1

## Recent investments (newest 5 of 97)

- Dec 2025: Beacon Therapeutics Limited (Series C, $75M)
- Aug 2025: Cyted Ltd (Series B)
- Jan 2025: Relief Cardiovascular (Series A, $12M)
- Oct 2024: Epitopea Limited (Unspecified Round, $31M)
- Sep 2024: F2G Ltd. (Series H, $100M)

## Questions

### How much does Advent Life Sciences invest per deal?

Based on the size of its funds, Advent Life Sciences writes estimated cheques of $1.8M–$10.8M. Lead cheques usually sit at the top of that range and follow-on cheques lower.

### What stages does Advent Life Sciences invest in?

Advent Life Sciences has invested at Seed, Series A, Series B, Series C, Series D and Series E. Its most frequent rounds on record are Series A, Series B and Series C.

### How much capital does Advent Life Sciences have left to invest?

Advent Life Sciences has an estimated $7.1M in dry powder: capital it has raised but not yet invested.

### What has Advent Life Sciences invested in recently?

Recent investments include Beacon Therapeutics Limited, Cyted Ltd and Relief Cardiovascular. It made 1 investments in the last 12 months.

### Where is Advent Life Sciences based?

Advent Life Sciences is headquartered in London, UK.

### How do I contact Advent Life Sciences?

Partner names, emails and LinkedIn profiles for Advent Life Sciences are on the Capital Atlas Pro and Team plans, which also draft outreach and track replies. Check the stages and cheque size above first, so you pitch a firm that fits your round.

## Get the full data

This file is the public profile. It leaves out:

- 92 more deals (97 in total), with amounts and co-investors
- 50 portfolio companies, with sector, stage at entry, year and status
- Its fund vehicles, with vintage, size and status
- Partner names, emails and LinkedIn profiles

### For the founder

1. Sign up free at https://capitalatlas.ai/login (or add an email on https://capitalatlas.ai/funds/advent-life-sciences) to see every deal, portfolio company, fund and office on the profile.
2. Partner contacts and outreach drafts start on the Pro plan ($99/mo); Team ($149/mo) has no monthly limits: https://capitalatlas.ai/pricing

### For you, the agent

- Connect the Capital Atlas MCP server: `https://capitalatlas.ai/api/mcp` (remote MCP over HTTP; the founder signs in with OAuth).
- Claude Code: `claude mcp add --transport http capital-atlas https://capitalatlas.ai/api/mcp`
- Other clients and setup steps: https://capitalatlas.ai/vc-mcp. How to use the tools: https://capitalatlas.ai/for-agents.md
- Call `atlas_mcp_status` first. On `free`, the tools are not available; send the founder the `upgradeUrl`.
- `get_fund_manager_profile` (fundManagerId `87d0d4d3-9c5a-4952-9af1-fdfe14d5838b`) returns the full profile, and on Pro or Team `find_relevant_contacts` returns partner contacts, for investors matched to the founder's startup.